Clinical characteristics and risk factors for tigecycline-induced pancreatitis in a tertiary hospital: a retrospective study.
Qinghai TanYu ZhangMei LiuDe'an TianXiaohui WuLei ZhouWenjuan FanPublished in: British journal of clinical pharmacology (2023)
The prevalence of TIP was low. Comorbid renal insufficiency was as an independent risk factor for TIP. Tigecycline is safe and efficient for treatment of pancreatitis, especially necrotizing pancreatitis, with intra-abdominal infection.